2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$8.04+$0.30 (+3.88%)
Price as of Jun 23, 2026 7:57 PM EDT- $499.4MMarket Cap
- 4.59%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$8.04+$0.30 (+3.88%)
ARVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.74 | ||
Change | +$0.07 (+0.91%) | ||
Open | $7.70 | ||
High | $7.76 | ||
Low | $7.48 | ||
Previous Close | $7.67 | ||
Volume | 711,451 | ||
30-Day Average Volume | 741,770 | ||
1-Week Change | 3.34% | ||
1-Month Change | -14.85% | ||
1-Year Change | 4.59% | ||
3-Year Change | -71.11% | ||
5-Year Change | -89.59% | ||
Fundamentals | |||
Shares Outstanding | 64.5M | ||
Total Assets | $647.5M | ||
Market Cap | $499.4M | ||
Enterprise Value | $412.6M | ||
Period: QTR TTM FY | |||
Revenue | $15.6M | ||
Net Income | -$57.6M | ||
Free Cash Flow | -$70.5M | ||
EBIT | -$57.5M | ||
EBITDA | -$56.8M | ||
Net Working Capital | $514.8M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue